BTIG analyst Kambiz Yazdi raised the price target on Zevra Therapeutics, Inc. (NASDAQ: ZVRA) to $27.00 (from $23.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE